Results

Total Results: 68 records

Showing results for "buprenorphine".

21. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=82
    January 01, 2024 - Wyse JJ , Morasco BJ , Dougherty J Adjunct interventions to standard medical management of buprenorphine … adjunctive interventions supportive of engagement and retention in treatment among patients receiving buprenorphine … effect on key outcomes of adjunctive interventions provided alongside standard medical management of buprenorphine … Adjunct interventions to standard medical management of buprenorphine in outpatient settings: a systematic

22. AHRQ News Now | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2
    April 26, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18 February 1, 2022 Buprenorphine

23. AHRQ News Now | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/index.html?order=field_date_created&page=2&sort=desc
    May 03, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18 February 1, 2022 Buprenorphine

24. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=444
    January 01, 2024 - Cost-effectiveness of injectable extended-release naltrexone compared with methadone maintenance and buprenorphine … cost-effectiveness of injectable extended-release naltrexone (XR-NTX) compared with methadone maintenance and buprenorphine … Cost-effectiveness of injectable extended-release naltrexone compared with methadone maintenance and buprenorphine

25. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=73
    January 01, 2024 - now": a qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine … Despite evidence demonstrating the safety and efficacy of buprenorphine for the treatment of emergency … In this study, the investigators explored barriers and facilitators to the prescription of buprenorphine … now": a qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine

26. AHRQ News Now | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/index.html?order=field_date_created&page=1&sort=asc
    January 19, 2022 - 25, 2022 AHRQ Stats: Hospital Admission Emergency Department Visits February 1, 2022 Buprenorphine

27. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=40
    January 01, 2024 - was conducted to estimate Medicaid participation prevalence among clinicians authorized to prescribe buprenorphine … Outcomes looked for were indicators of any Medicaid professional claims and Medicaid claims data for buprenorphine … Drug Enforcement Administration to identify clinicians who used the DEA waiver required to prescribe buprenorphine … Prevalence of prescribing buprenorphine to Medicaid beneficiaries ranged from 30.3% among specialist

28. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=19
    January 01, 2024 - They asked specific questions about buprenorphine use and open-ended questions about other available … Of the 160 facilities identified 39 (24.4%) offered buprenorphine, including through partnerships with … Among the 121 facilities that did not offer buprenorphine or were unsure, 57 indicated that adolescents … who were prescribed buprenorphine by their own clinician could continue receiving it, at least temporarily

29. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=354
    January 01, 2024 - Healthcare, Racial and Ethnic Minorities Tetrault JM , Tate JP , Edelman EJ Hepatic safety of buprenorphine … The purpose of this paper was to examine risk for buprenorphine (BUP)-associated hepatotoxicity among … Hepatic safety of buprenorphine in HIV-Infected and uninfected patients with opioid use disorder: the

30. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=48
    January 01, 2024 - for OUD using the Diagnostic Statistical Manual of Diseases-5th Edition criteria; use of methadone or buprenorphine … use of multimodal, nonopioid therapy, and when needed, short-acting opioid analgesics in addition to buprenorphine … or methadone, for acute pain management; ensuring linkage to ongoing methadone or buprenorphine treatment … A total of 1141 physicians who were publicly listed buprenorphine-prescribing physicians were surveyed

31. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=30
    January 01, 2024 - Engagement Cook RR , Foot C , Arah OA Estimating the impact of stimulant use on initiation of buprenorphine … Stimulant use had a larger negative impact on XR-NTX initiation compared to buprenorphine, especially … The researchers concluded that stimulant use is a barrier to buprenorphine or XR-NTX initiation in clinical … Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone

32. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=187
    January 01, 2024 - McClellan C , Fingar KR , Ali MM AHRQ Author: McClellan C Price elasticity of demand for buprenorphine … insurance coverage, the researchers examined the relationship between cost sharing and the number of buprenorphine … Price elasticity of demand for buprenorphine/naloxone prescriptions.

33. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=225
    January 01, 2024 - Elderly, Health Information Technology (HIT), Medication Hartung DM , Johnston K , Geddes J Buprenorphine … This letter discusses a study which looked into coverage of buprenorphine for opioid use disorder (OUP … Buprenorphine coverage in the Medicare Part D program for 2007 to 2018.

34. Out-of-Pocket Prescription Expenses To Treat Opioid Use Disorders Are High | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/791.html
    November 01, 2021 - Medical Expenditure Panel Survey to estimate the financial costs faced by the population receiving buprenorphine

35. New Data Resource Provides Insights on Factors Related to Falls | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/886.html
    October 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine

36. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=79
    January 01, 2024 - balanced by reductions in mortality while receiving medication-assisted treatment (MAT) with methadone or buprenorphine … Methadone treatment for 4 months or longer or buprenorphine for 2 months or longer resulted in 54 and … necessary to achieve net mortality benefits of 2 months or longer for methadone and 1 month or longer for buprenorphine

37. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=158
    January 01, 2024 - Quality Improvement, Quality of Care Samples H , Williams AR , Crystal S Impact of long-term buprenorphine … Impact of long-term buprenorphine treatment on adverse health care outcomes In Medicaid. … Impact of long-term buprenorphine treatment on adverse health care outcomes In Medicaid..

38. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=75
    January 01, 2024 - Evidence supports treatment for opioid use disorder (OUD) with buprenorphine in primary care practices … This study aimed to increase the number of rural PCPs providing OUD treatment with buprenorphine. … described the impact of a practice team training on the implementation and delivery of OUD treatment with buprenorphine

39. CMS Announces Temporarily Expanded Telehealth Coverage, Telehealth Toolkits for Medicare Beneficiaries | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletter/e-newsletter/705.html
    March 01, 2020 - Literature Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine

40. Final Progress Report: Advancing Patient Safety Implementation through Pharmacy-Based Opioid Medication Use Research (pdf file)
    www.ahrq.gov/sites/default/files/2024-02/green-report.pdf
    January 01, 2024 - not conducted due to data quality concerns. 6 Treatment and harm reduction uptake, defined as buprenorphine … dispensing naloxone and a greater number of naloxone doses dispensed (both p<0.05) had higher volumes of buprenorphine … naloxone experience is more consistent with pharmacy-based studies of nonprescription syringe access and buprenorphine … telling that our analysis indicated greater naloxone provision in pharmacies with higher rates of buprenorphine